Invesco
VOR icon

Invesco’s Vor Biopharma VOR Stock Holding History

Invesco’s Portfolio VOR Stock Details VOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$207K Buy
+11,600
New +$164K ﹤0.01% 3476
2024
Q2 		– Sell
-869
Closed -$41.2K – 3976
2024
Q1 		$41.2K Sell
869
-33
-4% -$1.45K ﹤0.01% 3817
2023
Q4 		$40.6K Buy
902
+176
+24% +$7.26K ﹤0.01% 3764
2023
Q3 		$30.8K Hold
726
– – ﹤0.01% 3826
2023
Q2 		$44.9K Buy
+726
New +$66.3K ﹤0.01% 3823

Other funds holding VOR

TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Invesco's VOR Position: Q1 2026 in Review

Invesco opened a new position in Vor Biopharma (VOR) in Q1 2026: 11,600 shares worth $207K. The stake represents ﹤0.01% of the portfolio and ranks #3476 among its holdings. This is a return to the name: Invesco previously reported a position in VOR as recently as Q1 2024.

Invesco first reported a position in VOR in Q2 2023 and has held it in 5 quarters since. 80 funds tracked by Wall St. Rank hold VOR as of Q1 2026.

  • Invesco held 11,600 shares of Vor Biopharma worth $207K as of Q1 2026.
  • Vor Biopharma was a new Invesco position in Q1 2026.
  • Vor Biopharma made up ﹤0.01% of Invesco's portfolio in Q1 2026, its #3476 holding.
  • Invesco first reported a position in Vor Biopharma in Q2 2023 and has held it in 5 quarters since.
  • 80 funds tracked by Wall St. Rank held Vor Biopharma as of Q1 2026.

Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.